BHV-1510, a highly differentiated Trop2 ADC incorporating the proprietary TopoIx payload, demonstrates early clinical activity and favorable safety profile in Phase 1 study as a monotherapy and in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback